Kintor Pharmaceutical Ltd
HKEX:9939
Kintor Pharmaceutical Ltd
HKEX:9939
Price:
4.15
HKD
-10.17%
Market Closed
Market Cap:
HK$2.1B
Relative Value
The Relative Value of one
Kintor Pharmaceutical Ltd
stock under the Base Case scenario is
0.28
HKD.
Compared to the current market price of 4.15 HKD,
Kintor Pharmaceutical Ltd
is
Overvalued by 93%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
0.28
HKD
Overvaluation 93%
Multiples Across Competitors
Competitors Multiples
Kintor Pharmaceutical Ltd Competitors
Kintor Pharmaceutical Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Kintor Pharmaceutical Ltd
HKEX:9939
|
2.1B HKD | 165.8 | -10.9 | -11 | -11 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
369.9B USD | 6 | 88.2 | 14.6 | 20.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190B USD | 5.2 | 24.7 | 14.3 | 14.3 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
175.3B USD | 6 | 20.6 | 12.9 | 15.9 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.3B USD | 9.6 | 29.3 | 22 | 23 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.1B USD | 5.5 | 17.6 | 13 | 14.8 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.1B AUD | 3.1 | 34.1 | 11.3 | 14.2 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| NL |
|
argenx SE
XBRU:ARGX
|
36.5B EUR | 10.4 | 33.4 | 36.1 | 36.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
